U S PHYSICAL THERAPY INC /NV Repayments of Long-Term Debt
U S PHYSICAL THERAPY INC /NV (USPH) reported Repayments of Long-Term Debt of $1.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV repayments of long-term debt for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV repayments of long-term debt for the quarter ending 2026-03-31 was $1.88M, a 50.00% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV repayments of long-term debt for the quarter ending 2025-12-31 was $1.88M.
- U S PHYSICAL THERAPY INC /NV repayments of long-term debt for the quarter ending 2025-09-30 was $1.88M, a 0.00% change year-over-year.
- U S PHYSICAL THERAPY INC /NV repayments of long-term debt for fiscal 2025 was $9.38M, a 150.00% increase from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV repayments of long-term debt for fiscal 2024 was $3.75M, a 0.00% change from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV repayments of long-term debt for fiscal 2023 was $3.75M, a 100.00% increase from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV repayments of long-term debt for fiscal 2022 was $1.88M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.88M 10-Q · filed 2026-08-07 | $3.75M derived: sum of 3 quarters · filed 2026-08-07 | $5.63M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.88M 10-Q · filed 2026-05-08 | $3.75M derived: sum of 2 quarters · filed 2026-05-08 | $5.63M derived: sum of 3 quarters · filed 2026-05-08 | $7.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.75M derived: sum of 2 quarters · filed 2026-02-27 | $5.63M derived: sum of 3 quarters · filed 2026-08-07 | $9.38M 10-K · filed 2026-02-27 |
| 2025-09-30 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.75M derived: sum of 2 quarters · filed 2026-08-07 | $7.50M 10-Q · filed 2025-11-07 | $7.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $5.63M 10-Q · filed 2026-08-07 | $5.63M derived: sum of 3 quarters · filed 2026-08-07 | $7.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $3.75M 10-Q · filed 2026-05-08 | $3.75M derived: sum of 2 quarters · filed 2026-05-08 | $5.63M derived: sum of 3 quarters · filed 2026-05-08 | $6.56M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.88M derived: sum of 2 quarters · filed 2026-02-27 | $2.81M derived: sum of 3 quarters · filed 2026-02-27 | $3.75M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.81M derived: sum of 2 quarters · filed 2025-11-07 | $3.75M 10-Q · filed 2025-11-07 | $4.69M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $937.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $1.88M 10-Q · filed 2025-08-08 | $2.81M derived: sum of 3 quarters · filed 2026-02-27 | $3.75M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $938.00K 10-Q · filed 2025-05-09 | $1.88M derived: sum of 2 quarters · filed 2026-02-27 | $2.81M derived: sum of 3 quarters · filed 2026-02-27 | $3.75M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $937.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.88M derived: sum of 2 quarters · filed 2026-02-27 | $2.81M derived: sum of 3 quarters · filed 2026-02-27 | $3.75M 10-K · filed 2026-02-27 |
| 2023-09-30 | $938.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.88M derived: sum of 2 quarters · filed 2024-11-08 | $2.81M 10-Q · filed 2024-11-08 | $2.91M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $937.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.88M 10-Q · filed 2024-08-14 | $1.97M derived: sum of 3 quarters · filed 2025-03-03 | $1.97M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $938.00K 10-Q · filed 2024-05-08 | $1.03M derived: sum of 2 quarters · filed 2025-03-03 | $1.03M derived: sum of 3 quarters · filed 2025-03-03 | |
| 2022-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $96.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.88M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.78M 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $1.78M 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |